The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Neuroendocrine Tumours: Revised Strategies from New Trial Data
Vienna, Austria / September 25-29, 2015
Guest Editor: Simron Singh, MD, MPHStaff Oncologist Assistant Professor, University of TorontoSunnybrook Health Sciences Centre Toronto, Ontario Introduction NET is a term for a genetically diverse group of solid tumours arising...
New Biologic Therapies in the Treatment of Ulcerative Colitis
Chicago, Illinois / May 3-6, 2014
Chicago - New biologic treatments for ulcerative colitis (UC) are being developed to offer advantages to patients with respect to administration route, dosing regimen and side effect profile; in addition, agents with different mechanisms of...
Optimizing Therapy with Biologic Agents in Inflammatory Bowel Disease
Chicago, Illinois / May 3-6, 2014
Chicago - Oral and poster presentations at DDW 2014 reflected the changes that have evolved in the approach to treatment of inflammatory bowel disease as new data have been accumulated on the use of the tumor necrosis factor alpha (TNF)...
PHYSICIAN PERSPECTIVE - Viewpoint based on current literature and presentations from the 19th Canadian Digestive Disease Week (CDDW) & 8th Annual CASL Winter Meeting
Update on Bowel Preparation Agents: Considering Efficacy, Tolerability and Safety for Optimal Compliance
Toronto, Ontario / February 8-11, 2014
Guest Editors:Stephen VannerProfessor of Medicine and PhysiologyQueen’s UniversityKingston, Ontario Lawrence HookeyAssociate Professor of MedicineQueen’s UniversityKingston, Ontario Introduction The effectiveness of...
New Insights into Strategies for Management of Crohn’s Disease and Ulcerative Colitis
Copenhagen, Denmark / February 20-22, 2014
Copenhagen - Numerous clinical trials have demonstrated the therapeutic value of treatment with monoclonal anti-TNF-a antibodies such as infliximab and adalimumab in luminal and/or fistulizing Crohn’s disease or ulcerative colitis,...
Update on Iron Deficiency Anemia in Gastrointestinal Disorders
San Diego, California / October 11-16, 2013
San Diego - Iron deficiency anemia (IDA) is widely prevalent among patients with gastrointestinal disease, mainly due to chronic blood loss as a result of mucosal damage, reduced duodenal absorption of dietary iron, and/or reduced dietary...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations and expert opinion from the New York Academy of Sciences (NYAS) Probiotics, Prebiotics, and the Host Microbiome: The Science of Translation and the 11th Annual Meeting of the International Scientific Association for Probiotics and Prebiotics (ISAPP)
The Microbiome and the Brain-Gut Axis: A Role for Prebiotics and Probiotics
New York, New York / June 12-14, 2013
Reviewed and Edited by:Eamonn Quigley, MD Chief, Division of Gastroenterology and Hepatology The Methodist Hospital and Weill Cornell College of MedicineHouston, Texas IntroductionThe influence of gut microbiota on hormone and...
Progress in Control of Constipation: Highly Specific Agents Change Treatment Algorithm
Orlando, Florida / May 18-21, 2013
Orlando - Pharmacologic control of constipation has improved as a result of progress in unraveling the brain-gut connection, according to data and expert opinion presented at the 2013 DDW meeting. Newer and emerging therapies are based on a...
The Potential of IV Iron Treatment in IBD Patients with Iron Deficiency Anemia
Vienna, Austria / February 14-16, 2013
Vienna - Anemia is the most common complication of inflammatory bowel disease (IBD), iron deficiency anemia (IDA) being the most prevalent cause. Correction of iron deficiency and IDA in IBD patients reduces the associated fatigue and...